ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Leukemia stem cells (LSCs) in CML are not dependent on BCR-ABL kinase activity for their survival and are insensitive to TKIs in a BCR-ABL-independent manner, therefore leading to relapse [25].